Search research articles
Contact Us
Filters
Showing results (91-100 of 99) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 99 results.
Journal for Immunotherapy of Cancer
|
March 29, 2022
eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma
Xisha Chen, Kuansong Wang, Shilong Jiang, et al.
Light, Science & Applications
|
March 6, 2025
Relay-projection microscopic telescopy
Wenjun Yi, Shuyue Zhu, Meicheng Fu, et al.
Nature Communications
|
April 16, 2021
Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor
Zizheng Zou, Xiyuan Hu, Tiao Luo, et al.
Frontiers in Pharmacology
|
September 13, 2021
The Efficacy of Pyrotinib as a Third- or Higher-Line Treatment in HER2-Positive Metastatic Breast Cancer Patients Exposed to Lapatinib Compared to Lapatinib-Naive Patients: A Real-World Study
D J Ouyang, Q T Chen, M Anwar, et al.
Eclinicalmedicine
|
July 7, 2025
Evaluating axillary lymph node metastasis risks in breast cancer patients via Semi-ALNP: a multicenter study
Limeng Qu, Jinfeng Zhu, Xilong Mei, et al.
Therapeutic Advances in Medical Oncology
|
November 3, 2025
Treatment beyond progression and rechallenge with pyrotinib in HER2-positive metastatic breast cancer and brain metastases: a multicenter real-world study
Jing Peng, Qitong Chen, Liping Liu, et al.
Frontiers in Oncology
|
March 22, 2021
Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis
Qitong Chen, Dengjie Ouyang, Munawar Anwar, et al.
Frontiers in Oncology
|
June 13, 2020
Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis
Qitong Chen, Dengjie Ouyang, Munawar Anwar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2021
Pyrotinib Treatment in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter Data
Munawar Anwar, Qitong Chen, Dengjie Ouyang, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 99) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 99 results.
Journal for Immunotherapy of Cancer
|
March 29, 2022
eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma
Xisha Chen, Kuansong Wang, Shilong Jiang, et al.
Light, Science & Applications
|
March 6, 2025
Relay-projection microscopic telescopy
Wenjun Yi, Shuyue Zhu, Meicheng Fu, et al.
Nature Communications
|
April 16, 2021
Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor
Zizheng Zou, Xiyuan Hu, Tiao Luo, et al.
Frontiers in Pharmacology
|
September 13, 2021
The Efficacy of Pyrotinib as a Third- or Higher-Line Treatment in HER2-Positive Metastatic Breast Cancer Patients Exposed to Lapatinib Compared to Lapatinib-Naive Patients: A Real-World Study
D J Ouyang, Q T Chen, M Anwar, et al.
Eclinicalmedicine
|
July 7, 2025
Evaluating axillary lymph node metastasis risks in breast cancer patients via Semi-ALNP: a multicenter study
Limeng Qu, Jinfeng Zhu, Xilong Mei, et al.
Therapeutic Advances in Medical Oncology
|
November 3, 2025
Treatment beyond progression and rechallenge with pyrotinib in HER2-positive metastatic breast cancer and brain metastases: a multicenter real-world study
Jing Peng, Qitong Chen, Liping Liu, et al.
Frontiers in Oncology
|
March 22, 2021
Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis
Qitong Chen, Dengjie Ouyang, Munawar Anwar, et al.
Frontiers in Oncology
|
June 13, 2020
Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis
Qitong Chen, Dengjie Ouyang, Munawar Anwar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2021
Pyrotinib Treatment in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter Data
Munawar Anwar, Qitong Chen, Dengjie Ouyang, et al.
Page
of 10